Showing results (31-40 of 263) with videos related to

Sort By:
Pageof 27
Surgical Neurology International|September 9, 2024
Transradial versus transfemoral access for middle meningeal artery embolization: Choice of the access route considering delirium in the elderlyManabu Yamamoto, Gaku Fujiwara, Hidesato Takezawa, et al.
Yonago Acta Medica|November 2, 2013
Scoring of prognostic parameters in patients with unresectable advanced or recurrent colorectal cancer undergoing chemotherapyMasahide Ikeguchi, Ryugo Shimoda, Manabu Yamamoto, et al.
NMC Case Report Journal|May 26, 2026
High-cervical Perimedullary Arteriovenous Fistula at C2: Staged Posterior Flow Control Followed by Transoral Direct Obliteration with Long-term IndependenceYuji Ueda, Katsumi Harada, Naoko Fujimura, et al.
Japanese Journal of Ophthalmology|February 16, 2013
Two-year results of reduced-fluence photodynamic therapy combined with intravitreal ranibizumab for typical age-related macular degeneration and polypoidal choroidal vasculopathyYusaku Yoshida, Takeya Kohno, Manabu Yamamoto, et al.
Oncology|October 11, 2013
Surgery after preoperative chemotherapy for patients with unresectable advanced gastric cancerManabu Yamamoto, Yoshihisa Sakaguchi, Ayumi Matsuyama, et al.
BMC Ophthalmology|April 20, 2022
Safety and efficacy of 27-gauge transconjunctival vitrectomy for the diagnosis of posterior uveitis or pan uveitis of unknown originAtsushi Sakai, Mizuki Tagami, Norihiko Misawa, et al.
Oncology Letters|June 29, 2012
Preliminary trial of surgery after chemotherapy for advanced gastric cancer with peritoneal disseminationManabu Yamamoto, Ayumi Matsuyama, Keiji Yoshinaga, et al.
Journal of Clinical Medicine|August 10, 2024
Switching to Intravitreal Brolucizumab after Ranibizumab or Aflibercept Using Treat and Extend Regimen for Neovascular Age-Related Macular Degeneration in Japanese Patients: 1-Year Results and Factors Associated with Treatment ResponsivenessKumiko Hirayama, Manabu Yamamoto, Shigeru Honda, et al.
Japanese Journal of Ophthalmology|March 3, 2023
Practical treatment options for persistent central serous chorioretinopathy and early visual and anatomical outcomesNaoko Yamada-Okahara, Akika Kyo, Kumiko Hirayama, et al.
Chemical & Pharmaceutical Bulletin|September 19, 2002
Synthesis and cyclic AMP phosphodiesterase 4 isoenzyme inhibitory activity of heterocycle condensed purinesHirokazu Suzuki, Manabu Yamamoto, Susumu Shimura, et al.
Pageof 27